abstract |
The present invention relates to compounds of formula (I) Such compounds are inhibitors of tyrosine kinases, particularly Met kinase, and can be used, inter alia, for the treatment of tumors:n n n n n n n n Wherein R 1 , R 2 , m, Q and B are as defined in claim 1.n n n Tyrosine / serine / threonine kinase, Met kinase inhibitor, solid tumor, thiadiazine derivative |